SB03, also known as Veregen® (sinecatechins), 10% is an ointment indicated for the topical treatment of external genital and perianal warts (EGW) in patients 18 years and older. These warts are caused by the human papillomavirus (HPV) infection.
Veregen® is the first botanical drug approved for prescription use in the U.S. The NDA of Veregen® was approved by TFDA in March, 2013.

  • Natural and Safe

Contain catechins mixture, extracted from green tea leaves. With very good safety profile, systemic side effects are unlikely.

  • Good Efficacy

High complete clearance rate in baseline and newly emerging warts.

  • Lowest Recurrence Rate
  • Easy Patient-Applied Administration

No drug holiday

No wash off

More information please find the News or the website for MediGene (German).

Veregen® MOA

Veregen® Worldwide